LS
COV

Livforsakringsbolaget Skandia’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-43,528
Closed -$4.45M – 679
2014
Q4 		$4.45M Sell
43,528
-14,800
-25% -$1.42M 0.21% 107
2014
Q3 		$5.05M Sell
58,328
-11,300
-16% -$1M 0.19% 122
2014
Q2 		$6.28M Hold
69,628
– – 0.23% 103
2014
Q1 		$5.13M Buy
69,628
+66,128
+1,889% +$4.61M 0.19% 123
2013
Q4 		$238K Sell
3,500
-3,700
-51% -$241K 0.15% 134
2013
Q3 		$439K Sell
7,200
-922
-11% -$56.3K 0.3% 102
2013
Q2 		$452K Buy
+8,122
New +$470K 0.33% 94

Livforsakringsbolaget Skandia's COV Position: Q1 2015 in Review

Livforsakringsbolaget Skandia sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 43,528 shares — an estimated $4.45M sold.

Livforsakringsbolaget Skandia first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $6.28M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Livforsakringsbolaget Skandia reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 43,528 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $4.45M.
  • Livforsakringsbolaget Skandia first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Livforsakringsbolaget Skandia's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $6.28M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2015, filed 15 May 2015.